Author:
Dunning Jake,Kennedy Stephen B.,Antierens Annick,Whitehead John,Ciglenecki Iza,Carson Gail,Kanapathipillai Rupa,Castle Lyndsey,Howell-Jones Rebecca,Pardinaz-Solis Raul,Grove Jennifer,Scott Janet,Lang Trudie,Olliaro Piero,Horby Peter W.,
Funder
Wellcome Trust
Seventh Framework Programme
Publisher
Public Library of Science (PLoS)
Reference23 articles.
1. WHO. Categorization and prioritization of drugs for consideration for testing or use in patients infected with Ebola 2015. Available: http://www.who.int/medicines/ebola-treatment/2015_0703TablesofEbolaDrugs.pdf?ua=1.
2. WHO. Potential Ebola therapies and vaccines 2014 [February 19 2016]. Available: http://apps.who.int/iris/bitstream/10665/137590/1/WHO_EVD_HIS_EMP_14.1_eng.pdf?ua=1.
3. Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses;DF Florescu;Expert Rev Anti Infect Ther,2014
4. Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate;WC Magee;Antimicrob Agents Chemother,2005
5. Development of CMX001 for the Treatment of Poxvirus Infections;R Lanier;Viruses,2010
Cited by
80 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献